Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization

INTRODUCTION: Triple negative breast cancer is an aggressive disorder which accounts for at least 15% of breast cancer diagnosis and a high percentage of breast cancer morbidity, hence intensive research efforts are focused on the development of effective therapies to overcome the disease. Thymoquin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehanna, Mohammed M, Sarieddine, Rana, Alwattar, Jana K, Chouaib, Racha, Gali-Muhtasib, Hala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718962/
https://www.ncbi.nlm.nih.gov/pubmed/33293807
http://dx.doi.org/10.2147/IJN.S263797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718962/
https://www.ncbi.nlm.nih.gov/pubmed/33293807
http://dx.doi.org/10.2147/IJN.S263797

Ejemplares similares